Susquehanna International Group’s Fate Therapeutics FATE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$324K Buy
289,232
+111,872
+63% +$125K ﹤0.01% 4938
2025
Q1
$140K Buy
177,360
+69,946
+65% +$55.3K ﹤0.01% 5712
2024
Q4
$177K Buy
107,414
+50,653
+89% +$83.6K ﹤0.01% 5386
2024
Q3
$199K Buy
56,761
+3,468
+7% +$12.1K ﹤0.01% 4817
2024
Q2
$175K Sell
53,293
-40,043
-43% -$131K ﹤0.01% 4832
2024
Q1
$685K Sell
93,336
-59,173
-39% -$434K ﹤0.01% 3096
2023
Q4
$570K Sell
152,509
-282,623
-65% -$1.06M ﹤0.01% 3666
2023
Q3
$922K Sell
435,132
-50,226
-10% -$106K ﹤0.01% 2661
2023
Q2
$2.31M Sell
485,358
-386,856
-44% -$1.84M ﹤0.01% 1725
2023
Q1
$4.97M Buy
872,214
+835,597
+2,282% +$4.76M ﹤0.01% 1123
2022
Q4
$369K Sell
36,617
-89,625
-71% -$904K ﹤0.01% 3625
2022
Q3
$2.83M Buy
126,242
+9,890
+9% +$222K ﹤0.01% 1321
2022
Q2
$2.88M Buy
116,352
+61,539
+112% +$1.52M ﹤0.01% 1328
2022
Q1
$2.13M Sell
54,813
-51,390
-48% -$1.99M ﹤0.01% 1952
2021
Q4
$6.21M Buy
106,203
+19,989
+23% +$1.17M ﹤0.01% 1047
2021
Q3
$5.11M Buy
86,214
+53,206
+161% +$3.15M ﹤0.01% 1148
2021
Q2
$2.87M Sell
33,008
-9,149
-22% -$794K ﹤0.01% 1727
2021
Q1
$3.48M Sell
42,157
-28,622
-40% -$2.36M ﹤0.01% 1543
2020
Q4
$6.44M Sell
70,779
-62,505
-47% -$5.68M ﹤0.01% 870
2020
Q3
$5.33M Buy
133,284
+22,005
+20% +$880K ﹤0.01% 801
2020
Q2
$3.82M Buy
111,279
+75,969
+215% +$2.61M ﹤0.01% 980
2020
Q1
$784K Sell
35,310
-60,347
-63% -$1.34M ﹤0.01% 2317
2019
Q4
$1.87M Buy
95,657
+21,023
+28% +$411K ﹤0.01% 1431
2019
Q3
$1.16M Buy
74,634
+21,094
+39% +$328K ﹤0.01% 1862
2019
Q2
$1.09M Buy
+53,540
New +$1.09M ﹤0.01% 1936
2019
Q1
Hold
0
3500
2018
Q4
Hold
0
4017
2018
Q3
Sell
-22,895
Closed -$260K 3748
2018
Q2
$260K Sell
22,895
-5,539
-19% -$62.9K ﹤0.01% 2849
2018
Q1
$278K Sell
28,434
-20,700
-42% -$202K ﹤0.01% 2590
2017
Q4
$300K Buy
+49,134
New +$300K ﹤0.01% 2829